Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer

Natural killer (NK) cells have been implied in the resistance against certain tumors and virally-infected cells. The prognostic significance of tumor infiltrating NK cells in primary squamous cell lung carcinoma (SqCLC) has not been fully studied. Fifty patients with primary SqCLC were evaluated for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2002, Vol.35 (1), p.23-28
Hauptverfasser: Villegas, Francisco R., Coca, Santiago, Villarrubia, Vicente G., Jiménez, Rodrigo, Chillón, Marı́a Jesús, Jareño, Javier, Zuil, Marcos, Callol, Luis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 28
container_issue 1
container_start_page 23
container_title Lung cancer (Amsterdam, Netherlands)
container_volume 35
creator Villegas, Francisco R.
Coca, Santiago
Villarrubia, Vicente G.
Jiménez, Rodrigo
Chillón, Marı́a Jesús
Jareño, Javier
Zuil, Marcos
Callol, Luis
description Natural killer (NK) cells have been implied in the resistance against certain tumors and virally-infected cells. The prognostic significance of tumor infiltrating NK cells in primary squamous cell lung carcinoma (SqCLC) has not been fully studied. Fifty patients with primary SqCLC were evaluated for the presence of tumor infiltrating natural killer cells subset CD57 (TINK) after surgery. None of them received adjuvant therapy. Immunohistochemical studies of surgery pieces were performed by using the monoclonal antibody CD57. The number of TINK cells was counted by using a MICRON image analyzer. The total area studied for each tumor was of 1 cm 2. In this area, 50 intratumoral fields of 0.173 mm 2 were selected. The reference value used was the median (five TINK cells/field) of all tumors analyzed. After a minimun follow-up of 2 years the Kaplan–Meier method was used to obtain survival curves. Multivariate analysis were performed by using the Cox regression model. The survival was significantly better in patients with more than five TINK cells/field (Logrank P=0.0317). According to TNM classification, in those patients screened as stage IB (37 patients) the differences in survival were significantly higher (Logrank P=0.0016). In the multivariate analysis including TNM (surgical–pathologic stage), age, and endoscopy localization, the risk of death in patients with less than five TINK cells/field was 2.50 fold higher (CI 95%; range 1.07–5.85) than in those patients with more than five TINK cells/field. These results show that TINK cells appear to be a prognostic factor in the survival of patients with SqCLC. The possible antitumoral role of these cells in SqCLC is discussed.
doi_str_mv 10.1016/S0169-5002(01)00292-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71350737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169500201002926</els_id><sourcerecordid>71350737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-e3fca8e010581439b5582d5ed1488214420bfdecbb1d4571e2745bae3776c5503</originalsourceid><addsrcrecordid>eNqFkE2P1DAMhiMEYoeFnwDKBQSHQtwkTXtCaPiUVgIJOEdp6g6BtJ2NU9D-ezIfYo9c7Mtj-_XD2GMQL0FA8-prKV2lhaifC3hRWldXzR22gdbUVStlfZdt_iEX7AHRTyHAgOjuswsAo4UR3YbdfEnLbl4oB88p7OYwBu9mj3wZeV6nJfEwjyHm5HKYd3x2eU0u8l8hRkzcY4zEae0JM9--1abQfF9QnDPxPyH_4HS9umlZ6cjyuJYlxwPpIbs3ukj46Nwv2ff3775tP1ZXnz982r65qrxSMlcoR-9aFCB0C0p2vdZtPWgcQLVtDUrVoh8H9H0Pg9IGsDZK9w6lMY3XWshL9uy0d5-W6xUp2ynQIYybseSyBmRxIU0B9Qn0aSFKONp9CpNLNxaEPTi3R-f2INQKsEfntilzT84H1n7C4XbqLLkAT8-AI-_imMr_gW45qUwj9SHA6xOHRcfvgMmSLyY9DiGhz3ZYwn-i_AXvHJ8S</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71350737</pqid></control><display><type>article</type><title>Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Villegas, Francisco R. ; Coca, Santiago ; Villarrubia, Vicente G. ; Jiménez, Rodrigo ; Chillón, Marı́a Jesús ; Jareño, Javier ; Zuil, Marcos ; Callol, Luis</creator><creatorcontrib>Villegas, Francisco R. ; Coca, Santiago ; Villarrubia, Vicente G. ; Jiménez, Rodrigo ; Chillón, Marı́a Jesús ; Jareño, Javier ; Zuil, Marcos ; Callol, Luis</creatorcontrib><description>Natural killer (NK) cells have been implied in the resistance against certain tumors and virally-infected cells. The prognostic significance of tumor infiltrating NK cells in primary squamous cell lung carcinoma (SqCLC) has not been fully studied. Fifty patients with primary SqCLC were evaluated for the presence of tumor infiltrating natural killer cells subset CD57 (TINK) after surgery. None of them received adjuvant therapy. Immunohistochemical studies of surgery pieces were performed by using the monoclonal antibody CD57. The number of TINK cells was counted by using a MICRON image analyzer. The total area studied for each tumor was of 1 cm 2. In this area, 50 intratumoral fields of 0.173 mm 2 were selected. The reference value used was the median (five TINK cells/field) of all tumors analyzed. After a minimun follow-up of 2 years the Kaplan–Meier method was used to obtain survival curves. Multivariate analysis were performed by using the Cox regression model. The survival was significantly better in patients with more than five TINK cells/field (Logrank P=0.0317). According to TNM classification, in those patients screened as stage IB (37 patients) the differences in survival were significantly higher (Logrank P=0.0016). In the multivariate analysis including TNM (surgical–pathologic stage), age, and endoscopy localization, the risk of death in patients with less than five TINK cells/field was 2.50 fold higher (CI 95%; range 1.07–5.85) than in those patients with more than five TINK cells/field. These results show that TINK cells appear to be a prognostic factor in the survival of patients with SqCLC. The possible antitumoral role of these cells in SqCLC is discussed.</description><identifier>ISSN: 0169-5002</identifier><identifier>EISSN: 1872-8332</identifier><identifier>DOI: 10.1016/S0169-5002(01)00292-6</identifier><identifier>PMID: 11750709</identifier><identifier>CODEN: LUCAE5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Aged ; Biological and medical sciences ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - surgery ; CD57 Antigens - metabolism ; Follow-Up Studies ; Humans ; Immunohistochemistry ; Killer Cells, Natural - metabolism ; Killer Cells, Natural - pathology ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Lymphocytes, Tumor-Infiltrating - immunology ; Lymphocytes, Tumor-Infiltrating - pathology ; Medical sciences ; Natural killer cells ; Neoplasm Staging ; Pneumology ; Prognosis ; Prognostic significance ; Smoking - adverse effects ; Squamous cell lung carcinoma ; Tumors of the respiratory system and mediastinum</subject><ispartof>Lung cancer (Amsterdam, Netherlands), 2002, Vol.35 (1), p.23-28</ispartof><rights>2002 Elsevier Science Ireland Ltd</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-e3fca8e010581439b5582d5ed1488214420bfdecbb1d4571e2745bae3776c5503</citedby><cites>FETCH-LOGICAL-c443t-e3fca8e010581439b5582d5ed1488214420bfdecbb1d4571e2745bae3776c5503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0169-5002(01)00292-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,4022,27921,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13476357$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11750709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Villegas, Francisco R.</creatorcontrib><creatorcontrib>Coca, Santiago</creatorcontrib><creatorcontrib>Villarrubia, Vicente G.</creatorcontrib><creatorcontrib>Jiménez, Rodrigo</creatorcontrib><creatorcontrib>Chillón, Marı́a Jesús</creatorcontrib><creatorcontrib>Jareño, Javier</creatorcontrib><creatorcontrib>Zuil, Marcos</creatorcontrib><creatorcontrib>Callol, Luis</creatorcontrib><title>Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer</title><title>Lung cancer (Amsterdam, Netherlands)</title><addtitle>Lung Cancer</addtitle><description>Natural killer (NK) cells have been implied in the resistance against certain tumors and virally-infected cells. The prognostic significance of tumor infiltrating NK cells in primary squamous cell lung carcinoma (SqCLC) has not been fully studied. Fifty patients with primary SqCLC were evaluated for the presence of tumor infiltrating natural killer cells subset CD57 (TINK) after surgery. None of them received adjuvant therapy. Immunohistochemical studies of surgery pieces were performed by using the monoclonal antibody CD57. The number of TINK cells was counted by using a MICRON image analyzer. The total area studied for each tumor was of 1 cm 2. In this area, 50 intratumoral fields of 0.173 mm 2 were selected. The reference value used was the median (five TINK cells/field) of all tumors analyzed. After a minimun follow-up of 2 years the Kaplan–Meier method was used to obtain survival curves. Multivariate analysis were performed by using the Cox regression model. The survival was significantly better in patients with more than five TINK cells/field (Logrank P=0.0317). According to TNM classification, in those patients screened as stage IB (37 patients) the differences in survival were significantly higher (Logrank P=0.0016). In the multivariate analysis including TNM (surgical–pathologic stage), age, and endoscopy localization, the risk of death in patients with less than five TINK cells/field was 2.50 fold higher (CI 95%; range 1.07–5.85) than in those patients with more than five TINK cells/field. These results show that TINK cells appear to be a prognostic factor in the survival of patients with SqCLC. The possible antitumoral role of these cells in SqCLC is discussed.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>CD57 Antigens - metabolism</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Killer Cells, Natural - pathology</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Lymphocytes, Tumor-Infiltrating - immunology</subject><subject>Lymphocytes, Tumor-Infiltrating - pathology</subject><subject>Medical sciences</subject><subject>Natural killer cells</subject><subject>Neoplasm Staging</subject><subject>Pneumology</subject><subject>Prognosis</subject><subject>Prognostic significance</subject><subject>Smoking - adverse effects</subject><subject>Squamous cell lung carcinoma</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0169-5002</issn><issn>1872-8332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE2P1DAMhiMEYoeFnwDKBQSHQtwkTXtCaPiUVgIJOEdp6g6BtJ2NU9D-ezIfYo9c7Mtj-_XD2GMQL0FA8-prKV2lhaifC3hRWldXzR22gdbUVStlfZdt_iEX7AHRTyHAgOjuswsAo4UR3YbdfEnLbl4oB88p7OYwBu9mj3wZeV6nJfEwjyHm5HKYd3x2eU0u8l8hRkzcY4zEae0JM9--1abQfF9QnDPxPyH_4HS9umlZ6cjyuJYlxwPpIbs3ukj46Nwv2ff3775tP1ZXnz982r65qrxSMlcoR-9aFCB0C0p2vdZtPWgcQLVtDUrVoh8H9H0Pg9IGsDZK9w6lMY3XWshL9uy0d5-W6xUp2ynQIYybseSyBmRxIU0B9Qn0aSFKONp9CpNLNxaEPTi3R-f2INQKsEfntilzT84H1n7C4XbqLLkAT8-AI-_imMr_gW45qUwj9SHA6xOHRcfvgMmSLyY9DiGhz3ZYwn-i_AXvHJ8S</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Villegas, Francisco R.</creator><creator>Coca, Santiago</creator><creator>Villarrubia, Vicente G.</creator><creator>Jiménez, Rodrigo</creator><creator>Chillón, Marı́a Jesús</creator><creator>Jareño, Javier</creator><creator>Zuil, Marcos</creator><creator>Callol, Luis</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer</title><author>Villegas, Francisco R. ; Coca, Santiago ; Villarrubia, Vicente G. ; Jiménez, Rodrigo ; Chillón, Marı́a Jesús ; Jareño, Javier ; Zuil, Marcos ; Callol, Luis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-e3fca8e010581439b5582d5ed1488214420bfdecbb1d4571e2745bae3776c5503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>CD57 Antigens - metabolism</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Killer Cells, Natural - pathology</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Lymphocytes, Tumor-Infiltrating - immunology</topic><topic>Lymphocytes, Tumor-Infiltrating - pathology</topic><topic>Medical sciences</topic><topic>Natural killer cells</topic><topic>Neoplasm Staging</topic><topic>Pneumology</topic><topic>Prognosis</topic><topic>Prognostic significance</topic><topic>Smoking - adverse effects</topic><topic>Squamous cell lung carcinoma</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Villegas, Francisco R.</creatorcontrib><creatorcontrib>Coca, Santiago</creatorcontrib><creatorcontrib>Villarrubia, Vicente G.</creatorcontrib><creatorcontrib>Jiménez, Rodrigo</creatorcontrib><creatorcontrib>Chillón, Marı́a Jesús</creatorcontrib><creatorcontrib>Jareño, Javier</creatorcontrib><creatorcontrib>Zuil, Marcos</creatorcontrib><creatorcontrib>Callol, Luis</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Villegas, Francisco R.</au><au>Coca, Santiago</au><au>Villarrubia, Vicente G.</au><au>Jiménez, Rodrigo</au><au>Chillón, Marı́a Jesús</au><au>Jareño, Javier</au><au>Zuil, Marcos</au><au>Callol, Luis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer</atitle><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle><addtitle>Lung Cancer</addtitle><date>2002</date><risdate>2002</risdate><volume>35</volume><issue>1</issue><spage>23</spage><epage>28</epage><pages>23-28</pages><issn>0169-5002</issn><eissn>1872-8332</eissn><coden>LUCAE5</coden><abstract>Natural killer (NK) cells have been implied in the resistance against certain tumors and virally-infected cells. The prognostic significance of tumor infiltrating NK cells in primary squamous cell lung carcinoma (SqCLC) has not been fully studied. Fifty patients with primary SqCLC were evaluated for the presence of tumor infiltrating natural killer cells subset CD57 (TINK) after surgery. None of them received adjuvant therapy. Immunohistochemical studies of surgery pieces were performed by using the monoclonal antibody CD57. The number of TINK cells was counted by using a MICRON image analyzer. The total area studied for each tumor was of 1 cm 2. In this area, 50 intratumoral fields of 0.173 mm 2 were selected. The reference value used was the median (five TINK cells/field) of all tumors analyzed. After a minimun follow-up of 2 years the Kaplan–Meier method was used to obtain survival curves. Multivariate analysis were performed by using the Cox regression model. The survival was significantly better in patients with more than five TINK cells/field (Logrank P=0.0317). According to TNM classification, in those patients screened as stage IB (37 patients) the differences in survival were significantly higher (Logrank P=0.0016). In the multivariate analysis including TNM (surgical–pathologic stage), age, and endoscopy localization, the risk of death in patients with less than five TINK cells/field was 2.50 fold higher (CI 95%; range 1.07–5.85) than in those patients with more than five TINK cells/field. These results show that TINK cells appear to be a prognostic factor in the survival of patients with SqCLC. The possible antitumoral role of these cells in SqCLC is discussed.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>11750709</pmid><doi>10.1016/S0169-5002(01)00292-6</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0169-5002
ispartof Lung cancer (Amsterdam, Netherlands), 2002, Vol.35 (1), p.23-28
issn 0169-5002
1872-8332
language eng
recordid cdi_proquest_miscellaneous_71350737
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Aged
Biological and medical sciences
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
CD57 Antigens - metabolism
Follow-Up Studies
Humans
Immunohistochemistry
Killer Cells, Natural - metabolism
Killer Cells, Natural - pathology
Lung Neoplasms - pathology
Lung Neoplasms - surgery
Lymphocytes, Tumor-Infiltrating - immunology
Lymphocytes, Tumor-Infiltrating - pathology
Medical sciences
Natural killer cells
Neoplasm Staging
Pneumology
Prognosis
Prognostic significance
Smoking - adverse effects
Squamous cell lung carcinoma
Tumors of the respiratory system and mediastinum
title Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A15%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20significance%20of%20tumor%20infiltrating%20natural%20killer%20cells%20subset%20CD57%20in%20patients%20with%20squamous%20cell%20lung%20cancer&rft.jtitle=Lung%20cancer%20(Amsterdam,%20Netherlands)&rft.au=Villegas,%20Francisco%20R.&rft.date=2002&rft.volume=35&rft.issue=1&rft.spage=23&rft.epage=28&rft.pages=23-28&rft.issn=0169-5002&rft.eissn=1872-8332&rft.coden=LUCAE5&rft_id=info:doi/10.1016/S0169-5002(01)00292-6&rft_dat=%3Cproquest_cross%3E71350737%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71350737&rft_id=info:pmid/11750709&rft_els_id=S0169500201002926&rfr_iscdi=true